CAT
69
11
HD
32
3
CNP
57
3
RHI
38
3
SWK
61
2
FSLR
58
-2
AN
50
-2
MCD
42
-4
SJM
16
2
STI
11
-4
MRK
68
2
HPQ
37
2
LB
29
-4
CL
62
-2
SIG
47
-2
ALL
57
-3
MHK
52
2
MCO
73
2
MMM
56
4
XRAY
31
3
CAT
69
11
HD
32
3
CNP
57
3
RHI
38
3
SWK
61
2
FSLR
58
-2
AN
50
-2
MCD
42
-4
SJM
16
2
STI
11
-4
MRK
68
2
HPQ
37
2
LB
29
-4
CL
62
-2
SIG
47
-2
ALL
57
-3
MHK
52
2
MCO
73
2
MMM
56
4
XRAY
31
3
Financhill
Back

Protagonist Therapeutics, Inc. Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Sell
39

PTGX
Protagonist Therapeutics, Inc.

Last Price:
$87.86
Seasonality Move:
15.02%
Sell
48

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$60.04
Seasonality Move:
5.6%
Sell
39
Protagonist Therapeutics, Inc. (PTGX) is a Sell

Is Protagonist Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Protagonist Therapeutics, Inc. [PTGX] share price is $88.78. The Score for PTGX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
BioMarin Pharmaceutical, Inc. (BMRN) is a Sell

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $59.95. The Score for BMRN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics, Inc.'s stock price today?

  • The Protagonist Therapeutics, Inc. share price today is $88.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $59.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.08 Buy
Relative Strength Index (14 RSI): 53.49 Buy
Chaikin Money Flow: 87500 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.94 - 91.62) Sell
Bollinger Bands (100): (59.69 - 85.71) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.47 Buy
Relative Strength Index (14 RSI): 64.36 Buy
Chaikin Money Flow: 539549 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.18 - 58) Buy
Bollinger Bands (100): (52.66 - 57.48) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 88.31 Buy
20-day SMA: 89.12 Sell
50-day SMA: 83.99 Buy
200-day SMA: 61.33 Buy
8-day EMA: 72.97 Buy
20-day EMA: 44.31 Buy
50-day EMA: 21.47 Buy
200-day EMA: 5.94 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.15 Buy
20-day SMA: 55.14 Buy
50-day SMA: 54.22 Buy
200-day SMA: 57.72 Buy
8-day EMA: 58.06 Buy
20-day EMA: 56.02 Buy
50-day EMA: 54.99 Buy
200-day EMA: 58.35 Buy

Protagonist Therapeutics, Inc. Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.93 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.74 per share.

Protagonist Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):